Patients with myasthenia gravis suffer from a systemic autoimmune disease, primarily affecting the neuromuscular junctions, which leads to corresponding clinical manifestations. The essence of the disease is caused by immune dysfunction, where the body produces specific antibodies that affect the transmission of impulses. Patients typically experience general weakness, double vision, drooping eyelids, and in severe cases, weakened respiratory muscles leading to respiratory paralysis. The treatment of myasthenia gravis mainly involves medication, including corticosteroids, immunoglobulins, acetylcholinesterase inhibitors, and other immunosuppressants. Additionally, there are some newer drugs that modulate the immune system. Acupuncture treatment, as an important method of traditional Chinese medicine, can also be used in the management of myasthenia gravis, primarily to improve the patients' resistance, enhance physical constitution, and play a significant role in preventing complications and reducing the dosage of other medications. (Specific medications should be administered under the guidance of a physician.)